Fundz

Tela Bio, Inc. reported raising $2.07 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PUBLIC · TELADec 04, 2018$2.1M of $3.5M raised

Amount Raised

$2.07 Million

$2.07 Million sold, per SEC Form D (first sale Dec 4, 2018)

Round Type

Seed

BiotechnologyHealth Care

Quick answer

TELA Bio raised $2.07 Million in a Seed round, dated December 4, 2018.

How much did TELA Bio raise?
TELA Bio raised $2.07 Million in a Seed round on December 4, 2018.
What does TELA Bio do?
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the..
Who are the decision-makers at TELA Bio?
Fundz holds 1 contact at TELA Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as TELA Bio that raised within 45 days of this round, from Fundz verified event records.

  • Summit Therapeutics raised $25M on January 18, 2019.
  • Turnstone Biologics Corp raised $42M on January 18, 2019.
  • Gestalt Diagnostics raised $300K on January 17, 2019.
  • Embleema raised $3M (Seed) on January 9, 2019.
  • BioCardia raised $4M (Seed) on January 7, 2019.
  • NeuroOne Medical Technologies Corporation raised $400K (Seed) on January 4, 2019.

Who to call at TELA Bio, and when

A new round usually means TELA Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TELA Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TELA Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TELA Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TELA Bio

About

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TELA Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts66 people are listed at TELA Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TELA Bio's next move

See what Strategic adds

TELA Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.